| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Snap subsidiary signs multi-year Qualcomm chip deal for AR glasses | ||
| Fr | UFC signs Supersure as small business insurance partner | ||
| Fr | Milestone Pharmaceuticals plans real-world PSVT registry study | ||
| Fr | LiveOne partners with Team Boxing League for global streaming | ||
| Fr | Erayak pivots to U.S.-focused energy solutions brand | ||
| Fr | Baird reiterates Neutral rating on Affirm stock amid macro concerns | ||
| Fr | Baird reiterates Neutral rating on BlackBerry stock at $5 target | ||
| Fr | Wrap Technologies receives UK pre-order for 20 counter-drone systems | ||
| Fr | CoreWeave partners with Anthropic for AI model deployment | ||
| Fr | Needham raises Constellation Brands stock price target on demand outlook | ||
| Fr | Mizuho raises Alphabet stock price target on cloud growth outlook | ||
| Fr | Mizuho raises Alkermes stock price target to $53 on drug confidence | ||
| Fr | Mizuho reiterates Oracle stock rating on AI infrastructure edge | ||
| Fr | Canaccord lowers BlackBerry stock price target on valuation | ||
| Fr | H.C. Wainwright reiterates BioXcel Therapeutics stock rating at buy | ||
| Fr | B.Riley upgrades MacroGenics stock rating on ADAM9 ADC potential | ||
| Fr | Guggenheim raises Zentalis stock price target on ovarian cancer drug data | ||
| Fr | Expedia stock seen best positioned for U.S. growth by BofA | ||
| Fr | Guggenheim raises Abbvie stock price target to $249 on immunology | ||
| Fr | CPP Group explores sale of Blink unit, seeks new funding | ||
| Fr | Beneficient closes $8.75M funding deal with Quartus AI Fund | ||
| Fr | H.C. Wainwright reiterates Zentalis stock rating on pivotal dose selection | ||
| Fr | H.C. Wainwright reiterates Kymera Therapeutics stock rating at buy | ||
| Fr | H.C. Wainwright reiterates Oncolytics Biotech stock rating at buy | ||
| Fr | H.C. Wainwright reiterates Nurix stock rating, $32 target on catalysts |